港股复盘｜二月行情收官 港股止跌反弹 近150亿港元南向资金进场抄底

Market Overview - The Hong Kong stock market ended February with a rebound, with the Hang Seng Index closing at 26,630.54 points, up 249.52 points, a rise of 0.95%. However, the index recorded a cumulative decline of 2.76% for the month [1] - The Hang Seng Technology Index also saw a slight rebound, closing at 5,137.84 points, up 28.51 points, a rise of 0.56%, but it experienced a cumulative decline of 10.15% in February [4] Sector Performance - Gold stocks, including Tongguan Gold, saw a general increase, with Tongguan Gold rising over 3%, and other companies like Zhaojin Mining and Zijin Mining increasing by over 1%. Mengjinyuan (HK02585) surged over 11%, focusing on high-purity and light luxury gold diamond jewelry [3] - The innovative drug sector rebounded collectively, with companies like WuXi AppTec (HK02268) rising over 8%, and others like Basilea Pharmaceutica and CanSino Biologics increasing by over 6% [3] Investment Trends - Southbound funds significantly bought into Hong Kong stocks, with a net purchase of 14.997 billion HKD by the end of the trading day [6] - The pharmaceutical industry is expected to maintain a stable upward trend, with the upcoming ASCO GU conference showcasing over 70 studies led by Chinese experts, which may catalyze sector performance [6] Future Outlook - Analysts from浦银国际 noted that external market disturbances have weakened optimistic sentiment, with some trading indicators losing momentum. The Hang Seng Index remains above one standard deviation from the past five years, while the Hang Seng Technology Index is near its five-year average [8] - There are signs of stabilization in earnings expectations for A-shares and Hong Kong stocks, with potential upward revisions in earnings guidance for the upcoming reporting period, which could drive market performance [8]